These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33959190)

  • 21. Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma.
    Tang W; Cao Y; Ma X
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of prognosis-related alternative splicing events in kidney renal clear cell carcinoma.
    Zuo Y; Zhang L; Tang W; Tang W
    J Cell Mol Med; 2019 Nov; 23(11):7762-7772. PubMed ID: 31489763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
    Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH
    Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
    Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
    Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 9-gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co-expression and regression analyses.
    Zhu W; Ding M; Chang J; Liao H; Xiao G; Wang Q
    Chem Biol Drug Des; 2023 Feb; 101(2):422-437. PubMed ID: 36053927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.
    Zhang Y; Zhang Z; Zhang W; Hu H; Bao G
    Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas.
    Wang Z; Zhu L; Li K; Sun Y; Giamas G; Stebbing J; Peng L; Yu Z
    Cancer Gene Ther; 2022 Oct; 29(10):1418-1428. PubMed ID: 35370291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma.
    Guo X; Sun Z; Jiang S; Jin X; Wang H
    Aging (Albany NY); 2021 Mar; 13(6):8276-8289. PubMed ID: 33686951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
    Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
    Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
    J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma.
    Meng T; Huang R; Zeng Z; Huang Z; Yin H; Jiao C; Yan P; Hu P; Zhu X; Li Z; Song D; Zhang J; Cheng L
    Front Bioeng Biotechnol; 2019; 7():270. PubMed ID: 31681747
    [No Abstract]   [Full Text] [Related]  

  • 34. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
    Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
    BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of alternative splicing signatures in the prognosis of glioblastoma.
    Xie ZC; Wu HY; Dang YW; Chen G
    Cancer Med; 2019 Dec; 8(18):7623-7636. PubMed ID: 31674730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide Analysis of the Alternative Splicing Profiles Revealed Novel Prognostic Index for Kidney Renal Cell Clear Cell Carcinoma.
    Gao L; He RQ; Huang ZG; Dang YW; Gu YY; Yan HB; Li SH; Chen G
    J Cancer; 2020; 11(6):1542-1554. PubMed ID: 32047561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
    Xing L; Zhang X; Tong D
    DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis.
    Wang Q; Zhang H; Chen Q; Wan Z; Gao X; Qian W
    Dis Markers; 2019; 2019():5648783. PubMed ID: 31976022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of drug targets and prognosis projection for uterine carcinosarcoma based on alternative splicing events.
    Zhang X; Yin X; Zhang L; Ye Z; Liang G
    Comput Biol Med; 2023 Jan; 152():106346. PubMed ID: 36470146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Construction and Analysis of ceRNA Network and Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Deng L; Wang P; Qu Z; Liu N
    Front Genet; 2021; 12():667610. PubMed ID: 34567057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.